The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial
Fabio Efficace, Laura Cannella, Isabella Capodanno, Rosaria Sancetta et autres
it, us, nl (code pays fourni par la source)